Home > News > NanoViricides to raise $40M through occasional stock sales
March 8th, 2010
NanoViricides to raise $40M through occasional stock sales
Abstract:
Drug maker NanoViricides Inc. has filed documents stating that it will look to raise up to $40 million through the occasional sale of company stock, for as-yet undefined general corporate purposes.
The shelf registration statement filed with the U.S. Securities and Exchange Commission has not yet become effective, officials said, so no immediate offering has begun. The registration covers a sale period of three years.
Source:
masshightech.com
Bookmark:
| Related Links |
| Related News Press |
News and information
Organic solar cells reach record efficiency, benchmark for commercialization April 23rd, 2018
Remote-control shoots laser at nano-gold to turn on cancer-killing immune cells April 20th, 2018
New qubit now works without breaks: A universal design for superconducting qubits has been created April 19th, 2018
Observing biological nanotransporters: Chemistry April 19th, 2018
Investments/IPO's/Splits
Arrowhead Pharmaceuticals Reports Inducement Grants under NASDAQ Marketplace Rule 5635(c)(4) March 20th, 2018
Nanometrics to Present at the 30th Annual ROTH Conference February 27th, 2018
180 Degree Capital Corp. Reports Net Asset Value per Share of $2.60 as of December 31, 2017; A Decrease of 3.0% From Prior Quarter and an Increase of 11.1% From December 31, 2016 February 27th, 2018
Announcements
Organic solar cells reach record efficiency, benchmark for commercialization April 23rd, 2018
Remote-control shoots laser at nano-gold to turn on cancer-killing immune cells April 20th, 2018
New qubit now works without breaks: A universal design for superconducting qubits has been created April 19th, 2018
Observing biological nanotransporters: Chemistry April 19th, 2018
 |
||
 |
||
| The latest news from around the world, FREE | ||
 |
||
|
|
||
| Premium Products | ||
 |
||
|
Only the news you want to read!
Learn More |
||
 |
||
|
Full-service, expert consulting
Learn More |
||
|
|
||